High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis

(2009) M. RUDWALEIT et al.   JOURNAL OF RHEUMATOLOGY

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis

(2009) B. DIJKMANS et al.   JOURNAL OF RHEUMATOLOGY

Developments in the scientific and clinical understanding of the spondyloarthritides

(2009) Joachim Sieper   ARTHRITIS RESEARCH & THERAPY

Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double‐blind, active drug–controlled study

(2008) Michael E. Weinblatt et al.   ARTHRITIS AND RHEUMATISM

Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs

(2008) I. H. Song et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

(2008) Robert D. Inman et al.   ARTHRITIS AND RHEUMATISM

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

(2008) D. van der Heijde et al.   ARTHRITIS AND RHEUMATISM